发明公开
EP2392660A2 ENA Nucleic Acid Drugs Modifying Splicing in mRNA Precursor
审中-公开
ENA-Nukleinsäurearzneimittel，die das Splicing im mRNA-Vorläuferverändern
- 专利标题： ENA Nucleic Acid Drugs Modifying Splicing in mRNA Precursor
- 专利标题（中）： ENA-Nukleinsäurearzneimittel，die das Splicing im mRNA-Vorläuferverändern
-
申请号： EP11155691.6申请日： 2003-11-21
-
公开(公告)号： EP2392660A2公开(公告)日： 2011-12-07
- 发明人: Matsuo, Masafumi , Takeshima, Yasuhiro , Koizumi, Makoto
- 申请人： Matsuo, Masafumi , Nonprofit Organization Translational Research Organization of Duchenne Muscular Dystrophy , KNC Laboratories Co., Ltd , Takeshima, Yasuhiro
- 申请人地址： Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku Kobe-shi, Hyogo 650-0017 JP
- 专利权人： Matsuo, Masafumi,Nonprofit Organization Translational Research Organization of Duchenne Muscular Dystrophy,KNC Laboratories Co., Ltd,Takeshima, Yasuhiro
- 当前专利权人： Matsuo, Masafumi,Nonprofit Organization Translational Research Organization of Duchenne Muscular Dystrophy,KNC Laboratories Co., Ltd,Takeshima, Yasuhiro
- 当前专利权人地址： Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku Kobe-shi, Hyogo 650-0017 JP
- 代理机构： Ford, Hazel
- 优先权： JP2002340857 20021125; JP2003204381 20030731
- 主分类号： C12N15/11
- IPC分类号： C12N15/11 ; C07H21/04 ; A61K31/7088 ; A61K31/712 ; A61K31/7125 ; A61K48/00 ; A61P21/04
摘要：
Oligonucleotides having a nucleotide sequence complementary to nucleotide numbers such as 2571-2607, 2578-2592, 2571-2592, 2573-2592, 2578-2596, 2578-2601 or 2575-2592 of the dystrophin cDNA (Gene Bank accession No. NM_004006.1) and therapeutic agents for muscular dystrophy comprising such oligonucleotides.
公开/授权文献
- EP2392660A3 ENA Nucleic Acid Drugs Modifying Splicing in mRNA Precursor 公开/授权日：2012-03-28
信息查询
IPC分类:
